is retatrutide a glp-1 drug Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, CBS News investigation Retatrutide for Weight Loss: TRIUMPH-1
Description
Blood pressure effects Both compounds reduce systolic blood pressure

10mg vial / 4mg per week = 2.5 weeks

Generell weisst, Swissmedic darauf hin, dass einige Anbieter neue Peptid-Wirkstoffe vertreiben, deren Wirksamkeit noch nicht klinisch belegt ist

E.BracyD

While hypothyroidism is characterized by an underactive thyroid gland and reduced thyroid hormone production, hyperthyroidism is marked by an overactive thyroid gland and excess thyroid hormone production
